PACAP stimulates colony formation and nuclear oncogene expression in NCI-N417 lung cancer cells, while PACAP antagonist treatment slows down small cell lung cancer growth (148, 149) and lower levels of PACAP were described in human lung cancer biopsies in comparison with neighboring healthy tissue (150). This evidence concerns the gene ADCYAP1 and small cell lung carcinoma.